2 Canadian Marijuana Stocks to Avoid Besides CannTrust (TSX:TRST)

Things were going quite well for CannTrust Holdings (TSX:TRST)(NYSE:CTST) only a few months ago, when shares reached just over $13 and the business was booming. But as the cannabis industry started to slump, terrible news came out for this cannabis company.

Back in July, it was discovered by Health Canada that the company was using five unlicensed rooms to produce cannabis. These rooms have since been approved by Health Canada; however, it has put a lot of product on hold, and the company may receive a fine up to $1,000,000 or even lose its licence.

The scandal has been all over the news, which is why many are saying you should avoid it like the plague. But in this uncertain time in the marijuana industry, I would also consider avoiding these two other companies for the time being.

Hexo

While Hexo (TSX:HEXO)(NYSE:HEXO) may look promising in the near term, it’s the long term that investors should be thinking about when buying cannabis stocks. Does the company really have what it takes to produce for years, even decades to come? In Hexo’s case, I don’t believe so.

The company has received a lot of excitement lately over the edibles market. Hexo expects its profits to soar, with an increase of 452% in sales when edibles are legalized in Canada this October, with some products on the shelves by December. The company has been working with Molson Coors Canada to create cannabis-infused beverages and is even looking into everyday products to see how it could introduce cannabis-infused products to your grocery store.

Hexo believes it can do this after it launches its 600,000-square-feet facility space specifically meant for derivatives production, and through its five-year deal to supply cannabis to Quebec. However, if I were an investor I would wait to see how successful the derivatives market actually looks before investing in Hexo. There could be a lot of hype (see last year) for a whole lot of nothing. If that’s the case, Hexo could be sunk.

Cronos

A similar situation lies with Cronos Group (TSX:CRON)(NYSE:CRON) but within the cannabidiol (CBD) market. Like Hexo, this company has placed a lot on its bet that CBD will do well. The company has been growing immensely, mostly through acquisitions, with the funds it received from Altria a few months back. It’s generated a lot of excitement, as it looks like the company is continuing the grow, but does it warrant all that hype?

Cronos announced back in July it would be entering the United States CBD market, and it does look to be fairly lucrative according to Wall Street with value estimates of US$16 billion by 2025. This was followed by intentions to acquire Redwood Holding Group, an owner of popular CBD brand Lord Jones for US$300 million, giving it a place in the U.S.

So, while many investors are getting excited about Cronos’s future potential, it’s just that: potential. There really isn’t that much proof yet that CBD will be a huge move in the U.S. Meanwhile, Cronos is still trading fairly high, making now not a great time to invest in this company that is, frankly, still in set-up mode, with no plans for all of its cash on hand.

One tiny small-cap stock to bet on ahead of Cannabis 2.0 on October 17th…

The first wave of cannabis legalization minted millionaires out of everyday investors, and it might be about to happen again.

Because when edibles are legalized in Canada on October 17th, experts project a new $2.7 BILLION market will be born.

Our last legalization stock pick is already up 1,211%, and now we’re recommending one tiny small-cap stock before Cannabis 2.0.

This could be our next +1,000% winner in the cannabis space.

Hurry, the second wave of cannabis legalization is about to hit and this stock could skyrocket.

Click here to learn more!

More reading

Fool contributor Amy Legate-Wolfe has no position in any of the stocks mentioned. The Motley Fool owns shares of Molson Coors Brewing.

Source: The Fool
2 Canadian Marijuana Stocks to Avoid Besides CannTrust (TSX:TRST)
The Fool

The Motley Fool
Contributor at mjcanada.ca
The Motley Fool is dedicated to helping the world invest — better. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, mutual funds, and premium investing services.

In all we do, we take a different approach.

We believe – and have proven over decades – that the individual investor can beat the market.

We believe that anyone can do it, even if they don’t have a lot of time or money to devote to investing.

We believe in a long-term outlook, helping people build wealth over time.

We believe that the person best positioned to take care of your financial future is you.

And we work tirelessly on behalf of our hundreds of thousands of members who are enjoying the opportunities that come with having enough money to do the things that matter to them.

While we are headquartered in Alexandria, Va., The Motley Fool advocates for the individual investor around the globe with offices in the UK, Australia, Canada, Singapore, and Germany.

Related News